Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
주식 순위 #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
주가
$0.2219522
마지막 동기화: 2025-09-11
시가총액
$1.10B
변동 (1일)
0.04%
변동 (1년)
0.17%
국가
CN
거래 Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Hubei Biocause Pharmaceutical Co., Ltd. (000627)의 P/S 비율
August 2026 기준 P/S 비율 TTM: 0.16
Hubei Biocause Pharmaceutical Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0.16입니다. 2022년 말 기준 P/S 비율은 0.31였습니다.
Hubei Biocause Pharmaceutical Co., Ltd.의 P/S 비율 기록 (2000 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 0.16 -44.32%
2023 0.28 -9.91%
2022 0.31 -4.58%
2021 0.33 -40.28%
2020 0.55 -20.19%
2019 0.69 -22.30%
2018 0.89 32.65%
2017 0.67 -63.11%
2016 1.82 -93.34%
2015 27.32 249.63%
2014 7.81 114.32%
2013 3.65 -23.01%
2012 4.73 38.93%
2011 3.41 -36.39%
2010 5.36 1.98%
2009 5.25 133.47%
2008 2.25 -70.72%
2007 7.69 165.80%
2006 2.89 172.12%
2005 1.06 -63.15%
2004 2.88 -20.44%
2003 3.62 -72.89%
2002 13.37 64.55%
2001 8.12 4.25%
2000 7.79 0.00%
유사 기업 또는 경쟁사의 P/S 비율